Tilray Medical Expands Commercial Footprint in Europe

Tilray Medical offers a portfolio of medical cannabis products in over 20 countries.

I Stock 483300738
iStock

Tilray Brands today announced that its medical cannabis division, Tilray Medical, has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group. The new strategic partnership broadens Tilray Medical’s distribution of EU-GMP certified medical cannabis products across pharmacies and hospitals to support medical cannabis patient care.

Tilray Medical said it is one of the leading providers of EU-GMP certified medicinal cannabis in the world. Today, Tilray Medical offers a portfolio of medical cannabis products in over 20 countries that patients may access by consulting their healthcare practitioner.

More in Distribution